Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
The global oral thrombopoietin receptor agonists market was estimated at US$ 4.73 billion in 2023 and is projected to grow to US$ 9.95 billion by 2034, rising at a compound annual growth rate (CAGR) of 7% from 2024 to 2034
The debate over whether GLP-1 medications raise the risk of eye conditions that could lead to vision loss continues
(2016) Cancer immunotherapy with anti-CTLA-4 monoclonal antibodies induces antiinflammatory bowel disease
(7-10) Glutathione and related enzymes play a crucial role in defending the body against oxidative stress
US$ 26.62
US$ 24.95
US$ 20.91
US$ 22.51
US$ 22.32
